# Patsnap

> Patsnap is a Singapore-founded innovation intelligence company whose AI-native platform helps R&D and IP teams search, analyze, and act on the world's patents, scientific literature, and market data. Used by more than 10,000 organizations across 50-plus countries, its flagship Eureka platform applies large language models and specialized AI agents to compress labor-intensive tasks - prior art search, freedom-to-operate analysis, patent landscaping, and drug-discovery intelligence - from weeks into minutes.

- **Founded:** 2007
- **Headquarters:** Singapore
- **Founders:** Jeffrey Tiong (Founder & CEO), Guan Dian (Co-founder)
- **Team size:** 570-700+ employees (global headcount)
- **Products:** Patsnap Eureka, Eureka Life Sciences, Patsnap Analytics, Patsnap Discovery, Innovation Data APIs
- **Notable:** Reached unicorn status (US$1B+ valuation) with its 2021 Series E - one of the first NUS-supported unicorns., Raised $300M in Series E, among the largest funding rounds for a Singapore enterprise-software company., Surpassed US$100M in annual recurring revenue (2023), with roughly 20% year-over-year growth.

## Products & services

- **Patsnap Eureka** — AI-native innovation intelligence platform with domain-specific AI agents for prior art search, freedom-to-operate analysis, patent landscaping, and innovation scouting. Processes 2B+ data points across 20 domains.
- **Eureka Life Sciences** — Agentic intelligence suite for biopharma R&D combining proprietary datasets with multimodal LLM-based reasoning for drug discovery, biosequence and chemical structure search.
- **Patsnap Analytics** — Connected patent and innovation analytics for IP portfolio management, competitive benchmarking, patent landscaping and legal-status tracking across global jurisdictions.
- **Patsnap Discovery** — R&D and technology-scouting workspace surfacing scientific literature, emerging technologies and innovation trends for corporate strategy teams.
- **Innovation Data APIs** — Open API access to global patent data, legal status, and innovation datasets for enterprise integration.

## Achievements

- Reached unicorn status (US$1B+ valuation) with its 2021 Series E - one of the first NUS-supported unicorns.
- Raised $300M in Series E, among the largest funding rounds for a Singapore enterprise-software company.
- Surpassed US$100M in annual recurring revenue (2023), with roughly 20% year-over-year growth.
- Grew to serve 10,000+ customers across 50+ countries.
- Launched Eureka, an AI-native platform reporting up to 75% productivity gains for IP and R&D workflows.

## Latest updates

- **2025-07** — Patsnap expanded Eureka with new AI agents for tech R&D and a purpose-built Eureka Life Sciences suite for biopharma.
- **2023-01** — Announced crossing US$100M in annual recurring revenue.
- **2021-03** — Closed $300M Series E led by SoftBank Vision Fund 2 and Tencent, reaching unicorn valuation.

## Links

- Website: https://www.patsnap.com
- LinkedIn: http://www.linkedin.com/company/patsnap
- Twitter/X: https://twitter.com/PatSnap
- YouTube: https://www.youtube.com/c/Patsnap
- Facebook: https://facebook.com/PatSnap

---

Profile page: https://yespress.io/patsnap
Published by YesPress — https://yespress.io
Last updated: 2026-07-25